KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) EBT Margin: 2015-2025

Historic EBT Margin for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 10.42%.

  • BeOne Medicines' EBT Margin rose 2023.00% to 10.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.67%, marking a year-over-year increase of 2774.00%. This contributed to the annual value of -13.99% for FY2024, which is 1960.00% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' EBT Margin is 10.42%, which was up 37.68% from 7.57% recorded in Q2 2025.
  • BeOne Medicines' EBT Margin's 5-year high stood at 29.35% during Q3 2023, with a 5-year trough of -320.40% in Q2 2021.
  • Moreover, its 3-year median value for EBT Margin was -9.81% (2024), whereas its average is -18.57%.
  • In the last 5 years, BeOne Medicines' EBT Margin soared by 70,824bps in 2021 and then slumped by 14,759bps in 2022.
  • Over the past 5 years, BeOne Medicines' EBT Margin (Quarterly) stood at -283.22% in 2021, then soared by 16,984bps to -113.38% in 2022, then spiked by 5,809bps to -55.29% in 2023, then skyrocketed by 4,772bps to -7.57% in 2024, then soared by 2,023bps to 10.42% in 2025.
  • Its EBT Margin stands at 10.42% for Q3 2025, versus 7.57% for Q2 2025 and 1.87% for Q1 2025.